Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FI-700

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Fms-like tyrosine kinase-3 (FLT3) inhibitors have been used to overcome the dismal prognosis of acute myeloid leukemia (AML) with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Internal tandem duplication of FMS-like receptor tyrosine kinase 3 (FLT3/ITD) within its juxtamembrane domain is a frequent… Expand
Is this relevant?
2011
2011
phorylated at T308. This result suggests that B55alpha is mediating dephosphorylation of AKT at T308 but not S473 in the AML… Expand
Is this relevant?
2010
2010
Treatment using Fms-like tyrosine kinase-3 (FLT3) inhibitors is a promising approach to overcome the dismal prognosis of acute… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2009
2009
Abstract 3108 Poster Board III-45 Background FLT3 (FMS-like receptor tyrosine kinase 3) is a member of the class III receptor… Expand
Is this relevant?
2007
2007
Purpose: The aim of this study was to evaluate the antileukemia activity of a novel FLT3 kinase inhibitor, FI-700. Experimental… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?